Indian Pharmaceutical companies, from Sun Pharma Ltd., to Lupin Ltd., Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Ltd., Gland Pharma Ltd., will be reacting on Wednesday, April 9, after US President Donald Trump said that he will be announcing major tariffs on the Pharma sector soon. Speaking at the Republican NRCC event, Trump said that major […]
Pharma Stocks Crash: Donald Trump says tariffs will be at ‘never seen before’ levels – CNBC TV18
Shares of Indian Pharma Companies, Aurobindo Pharma, IPCA Laboratories, Lupin and others fell up to 5% on Friday, April 4, after US President Donald Trump remarked about the upcoming tariffs on the sector. “Pharma tariffs are going to come in at levels you have never seen before. We are looking at pharmaceuticals as a separate […]
Stocks to Watch on March 5: Biocon, Adani Wilmar, Ola Electric, Power Grid and more – CNBC TV18
1 / 14 Biocon | Biotechnology firm said its wholly-owned subsidiary, Biocon Pharma Ltd, has received final approvals from the US Food and Drug Administration (FDA) for its abbreviated new drug applications (ANDAs). Lenalidomide capsules, in 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg and 25 mg strengths. Lenalidomide is a medication used […]
USFDA asks Dr Reddy’s to sort out issues at its Hyderabad facility – CNBC TV18
Drug major Dr Reddy’s Laboratories Ltd on Tuesday (February 25) said the United States Food and Drug Administration (USFDA) found some issues at its active pharmaceutical ingredient (API) manufacturing facility (CTO-2) in Bollaram, Hyderabad, and asked it to sort them out. “Further to our intimation dated November 19, 2024, on the inspection conducted by the United […]
Kazakhstan fines Dr Reddy’s subsidiary ₹28.7 lakh for discontinuing some expense claims – CNBC TV18
Drug firm Dr Reddy’s Laboratories Ltd on Thursday (December 5) announced that its step-down wholly owned subsidiary, Dr Reddy’s Laboratories Kazakhstan LLP, has received a penalty order from the Department of State Revenue, Bostandyk district, Almaty, Kazakhstan. Company Value Change %Change “This is to inform that our step-down wholly owned subsidiary “Dr Reddy’s Laboratories Kazakhstan […]
Dr Reddy’s API facility in Hyderabad receives 7 USFDA observations following inspection – CNBC TV18
Dr Reddy’s Laboratories Ltd on Tuesday (November 19) announced the completion of a Good Manufacturing Practices (GMP) inspection by the United States Food and Drug Administration (USFDA) at its Active Pharmaceutical Ingredient (API) manufacturing facility (CTO-2) in Bollaram, Hyderabad. “This is to inform you that the United States Food & Drug Administration (USFDA) today completed […]
Trade Setup for October 9: Will Nifty bulls use this rebound to exit from longs? – CNBC TV18
There was green on the screen, finally. More importantly, green that sustained through the day. From writing about the Nifty being above 26,000 just two weeks prior, the bulls will see 25,000 on the Nifty as a sigh of relief post Tuesday’s close. The benchmark index snapped a six-day losing streak on Tuesday, which led […]
Trade Setup for September 11: Nifty continues recovery but is it the calm before the storm? – CNBC TV18
The market has a mind of its own. On a day when the street expected a repeat of Friday’s declines courtesy of the sell-off on Wall Street, the Nifty ended higher. The Nifty ended higher on Tuesday as well, but then the gains were not as much as the street anticipated, considering the strong handover […]
Dr Reddy’s Labs gets VAI classification for Andhra Pradesh facility from USFDA – CNBC TV18
Dr Reddy’s Laboratories Ltd on Friday, September 6, announced that it has received an Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA) for its manufacturing facility (CTO-6) in Srikakulam, Andhra Pradesh. The inspection has been classified as “Voluntary Action Indicated” (VAI) by the US drug regulator, meaning that while some minor […]
Trade Setup for July 29: Will the Nifty finally cross 25,000 led by a revival in banks? – CNBC TV18
On Friday morning, we had asked the question that even as the dips have been bought into every single session of the week, but do the bulls have the conviction and the strength to take the Nifty back towards levels seen on July 19, which was above the mark of 24,800? Well, if the price […]